Patent ID: 7943666

Claim:
A pharmaceutical composition comprising: (a) a compound of formula (Ia): wherein R 1 is selected from the group consisting of (CH 2 ) 4 (CH) 2 CH(CH 3 ) 2 (capsaicin ester); (CH 2 ) 5 (CH) 2 CH(CH 3 ) 2 (homocapsaicin ester; (CH 2 ) 5 CH(CH 3 ) 2 (nordihydrocapsaicin ester); (CH 2 ) 6 CH(CH 3 ) 2 (dihydrocapsaicin ester); (CH 2 ) 7 CH(CH 3 ) 2 (homodihydrocapsaicin ester); (CH 2 ) 6 CH 3 (n-vanillyloctanamide ester); (CH 2 ) 8 CH 3 (n-vanillyldecanamide ester); and (CH 2 ) 4 (CH) 2 CH(CH 3 ) 2 (civamide ester) and (b) an ester of myristoleic acid of formula (Ib): wherein R of formula (Ia) and (Ib) are independently is selected from alkyl groups of up to about 18 carbon atoms and aryl groups of up to about 18 carbon atoms and alkylene group of up to about 18 carbon atoms and an arylene group of up to about 18 carbon atoms, with the proviso that when R of formula (Ia) is alkyl, it is not methyl, wherein the alkyl, aryl and alkylene groups may be substituted or unsubstituted, branched or straight chains, wherein R may contain heteroatoms such as O, N, Cl, F, Br, I and S and may be straight chained or branched.